in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
PCI Synthesis appoints new v.p./business development
9:45 AM MDT | October 7, 2013 | Deepti Ramesh
PCI Synthesis (Newburyport, MA), a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates, and other specialty products, says it has appointed Glenn Killingworth as v.p./business development. A specialist in the field of organic chemistry, Killingworth brings 25 years of experience working for specialist companies, including former Fisher Scientific, Peakdale Molecular (High Peak, UK), Almac Sciences (Craigavon, UK), WuXi Apptec (Shanghai), and Asymchem (Morrisville, NC)...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee